| CAS NO: | 2119669-71-3 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
Asciminib HCl (ABL001; ABL-001; Scemblix), the hydrochloride salt of Asciminib, is an allosteric inhibitor of BCR-ABL1 that has been approved FDA on Oct 29th 2021 for treating Philadelphia chromosome-positive CML (chronic myeloid leukemia).
纯度：≥98%
CAS：2119669-71-3
m.cnreagent.com